A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of REGN3500 and Dupilumab in Patients With Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Vascular Effects of Alirocumab in Acute MI-Patients
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
- Status
- COMPLETED
- Phase
- NA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
- Status
- COMPLETED
- Phase
- PHASE4
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
- Status
- UNKNOWN
- Phase
- PHASE4